AMC | Earnings Review

AMC Entertainment Holdings | 2026Q1 reported May 5, 2026 | Analysis date: July 22, 2026

• The North American box office rose 22% YoY, helping AMC produce its best first-quarter adjusted EBITDA since 2019.
• Revenue beat Zacks consensus by about 4.8%, but adjusted diluted EPS of $(0.36) missed the $(0.32) estimate.
• Management now frames 2026 North American box office at $500 million-$1.2 billion above 2025 and maintained net CapEx at $175 million-$225 million. It still gave no AMC revenue, EBITDA, or free-cash-flow range.
• The $400 million 2027 refinancing and $155.8 million note conversion reduce near-term maturity risk, but dilution and cash interest remain central risks.
• Credibility is mixed: management's 2025 box-office forecast missed materially, and the XL rollout appears to have shifted from end-2026 toward end-2027.

| Metric | 24Q2 | 24Q3 | 24Q4 | 25Q1 | 25Q2 | 25Q3 | 25Q4 | 26Q1 | |---|---:|---:|---:|---:|---:|---:|---:|---:| | Revenue ($m) | 1,030.6 | 1,348.8 | 1,306.4 | 862.5 | 1,397.9 | 1,300.2 | 1,288.3 | 1,045.4 | | Revenue YoY | -23.5% | -4.1% | +18.3% | -9.3% | +35.6% | -3.6% | -1.4% | +21.2% | | Attendance (m) | 50.0 | 65.1 | 62.4 | 41.9 | 62.8 | 58.4 | 56.3 | 47.6 | | Adjusted EBITDA ($m) | 38.5 | 161.8 | 164.8 | (57.7) | 189.2 | 122.2 | 134.1 | 38.3 | | EBITDA margin | 3.7% | 12.0% | 12.6% | -6.7% | 13.5% | 9.4% | 10.4% | 3.7% | | Diluted EPS | $(0.10) | $(0.06) | $(0.35) | $(0.47) | $(0.01) | $(0.58) | $(0.25) | $(0.22) |

The trend is accelerating, but it remains slate-driven and volatile. 2026Q1 revenue grew faster than attendance, confirming continued per-patron monetization; EBITDA conversion improved sharply but remains well below the double-digit margins achieved in stronger quarters.

Five-year trajectory

| Fiscal year | Revenue ($m) | YoY | Net loss ($m) | Adjusted EBITDA ($m) | |---|---:|---:|---:|---:| | 2021 | 2,527.9 | +103.5% | (1,269.8) | (291.7) | | 2022 | 3,911.4 | +54.7% | (973.6) | 46.6 | | 2023 | 4,812.6 | +23.0% | (396.6) | 425.8 | | 2024 | 4,637.2 | -3.6% | (352.6) | 343.9 | | 2025 | 4,848.9 | +4.6% | (632.4) | 387.5 |

| Metric | Consensus | Actual | Variance | Result | |---|---:|---:|---:|---| | Revenue | ~$997.7m | $1,045.4m | +$47.7m / +4.8% | Beat | | Adjusted diluted EPS | $(0.32) | $(0.36) | $(0.04) worse | Miss | | Adjusted EBITDA | Public point estimate unavailable | $38.3m | Management called it far above consensus | Positive, unquantified |

Archived consensus is incomplete for four of the last eight quarters, so no artificial eight-quarter hit rate is shown. The defensible pattern is that AMC has frequently exceeded revenue/EBITDA expectations while failing to convert that performance consistently into per-share earnings.

| Topic | Prior view | 2026Q1 update | Signal | |---|---|---|---| | North American box office | +$500m to more than $1bn vs 2025 | +$500m to $1.2bn | Reaffirmed; high end clarified | | AMC revenue | Rising in 2026 | Significantly rising | Qualitative only | | Adjusted EBITDA | Material improvement with revenue | No range; operating leverage reiterated | Constructive, unauditable | | Free cash flow | Outer-year path dependent on slate | No 2026 range or milestone | Key omission | | Net CapEx | $175m-$225m | $175m-$225m | Maintained |

Guidance quality improved only directionally. Q1 supports the operating-leverage thesis, but management's material miss on its 2025 box-office forecast warrants a discount to the new slate-based outlook.

Revenue YoY moved from -1.4% in 2025Q4 to +21.2% in 2026Q1, a 2,260-basis-point acceleration in the growth rate. Diluted EPS improved from $(0.47) to $(0.22) YoY, but share-count changes make the percentage growth rate less decision-useful. The most important inflections were the 2025Q2 slate surge, the 2025Q3-Q4 slowdown, and the 2026Q1 reacceleration.

| Catalyst | Timing | Confirmation | Principal failure condition | |---|---|---|---| | 2026 film-slate acceleration | Q2-H2 2026 | Industry box office reaches management range | Release underperformance or delays | | Operating leverage | Each quarter | EBITDA grows faster than revenue YoY | Margin compression despite growth | | Longer theatrical windows | 2026 onward | 45-day PVOD and ~90-day SVOD adherence | Studios revert to shorter windows | | Balance-sheet repair | 2026-2027 | Lower cash interest and leverage | Recurring equity issuance replaces cash generation | | Premium formats / seating | 2026-2027 | Installed counts and per-patron gains | XL schedule slips further | | Arena 1 | Launch planned June 2026 | Artists, sell-through, repeat events, economics | Low utilization or launch delay |

Arena 1 is option value, not base-case earnings: AMC described minimal upfront capital but did not disclose artists, cadence, revenue share, or EBITDA contribution.

| Question | Management response | Assessment | |---|---|---| | What are Arena 1's economics? | Minimal upfront spend, revenue share, possible $40-$75 tickets; no event cadence or retained share | Partially answered | | When can AMC sustain full-year positive FCF? | Cited positive April-December 2025 FCF and lower breakeven threshold; no timing or box-office threshold | Deflected on key milestone | | Can Europe close the contribution-margin gap? | Identified concessions, pricing, and contract differences; no target or timeline | Partially answered | | Is Netflix repeatable beyond Narnia? | Relationship is positive and both sides want more; no commitment disclosed | Partially answered | | Why convert $155.8m of notes now? | Mandatory share-price trigger; removes debt and covenants | Well answered | | How should investors view theatre closures? | Perpetual lease-by-lease pruning, not a fixed restructuring endpoint | Well answered |

The call was most specific on transaction mechanics and least specific on sustainable free cash flow, Arena 1 unit economics, and capital-allocation priorities.

Free-cash-flow messaging, merchandise growth, theatre pruning, Netflix engagement, and CapEx discipline reconcile across periods and are not genuine contradictions.

| Company / theme | Commentary | Read-through | |---|---|---| | Disney / Universal | Strong slate and support for longer windows | Positive for theatrical monetization and franchise reach | | Paramount / Skydance | Commitment to more films and longer windows | Positive if output promises are executed | | Amazon MGM | Rising theatrical output; Project Hail Mary set a studio record | Strong positive evidence for theatrical as a scaled channel | | Netflix | Successful AMC events and 49-day Narnia window | Positive experiment, not yet a broad strategic pivot | | Cinemark / Regal | AMC cited share gains and industry use of segmented pricing | Scale, premium inventory, and pricing sophistication matter | | European exhibition | Later but faster early-2026 recovery | Positive for Odeon and local-language film supply | | Consumer | Premium willingness to pay plus successful discount days | Bifurcated demand, not broad pricing weakness |

The ecosystem read-through is constructive: streamers increasingly use theatrical distribution as complementary monetization and marketing, while labor stability and longer windows improve supply visibility. Smaller, highly levered exhibitors remain disadvantaged if they cannot invest through release gaps.

AMC is an operational acceleration story with an unresolved capital-structure problem. The 2026Q1 recovery is genuine and measurable, but the investment case requires three confirmations: sustained box-office growth through H2, EBITDA growth that converts into trailing cash flow, and balance-sheet improvement without persistent dilution. Until then, rising theatre economics should not be mistaken for de-risked per-share value.